NOVEL REGULATION OF CHONDROITIN SULFATE GLYCOSAMINOGLYCAN MODIFICATION OF AMYLOID PRECURSOR PROTEIN AND ITS HOMOLOG, APLP2

Citation
G. Thinakaran et al., NOVEL REGULATION OF CHONDROITIN SULFATE GLYCOSAMINOGLYCAN MODIFICATION OF AMYLOID PRECURSOR PROTEIN AND ITS HOMOLOG, APLP2, The Journal of biological chemistry, 270(28), 1995, pp. 16522-16525
Citations number
30
Categorie Soggetti
Biology
ISSN journal
00219258
Volume
270
Issue
28
Year of publication
1995
Pages
16522 - 16525
Database
ISI
SICI code
0021-9258(1995)270:28<16522:NROCSG>2.0.ZU;2-P
Abstract
Alzheimer's disease is characterized by the presence of parenchymal an d cerebrovascular deposits of beta-amyloid (A beta). A beta is derived from larger amyloid precursor proteins (APP), a member of a family of related polypeptides that includes amyloid precursor-like proteins, A PLP1 and APLP2, APP and APLP2 isoforms are encoded by several alternat ively spliced APP and APLP2 transcripts, respectively, We previously r eported that the APLP2-751 isoform is modified by the addition of chon droitin sulfate glycosminoglycan (CS GAG) at Ser-614, In this report, we demonstrate that the APLP2-763 isoform, which contains an insertion of 12 amino acids immediately N-terminal to Ser-614, is not modified by CS GAG, Finally, we demonstrate that like APLP2-751, APP isoforms t hat lack sequences encoded by exon 15 (L-APP) are also modified by CS GAG, whereas APP forms containing exon 15 are not, We suggest that CS GAG modification of a subset of APP and APLP2 isoforms represents a me ans of generating functional diversity for these polypeptides.